Contract 75N93023C00015
Ceramedix Holding, Llc · Department Of Health And Human Services · August 20, 2024
Ceramedix Holding, Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 20, 2024 for $965,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in New York, NY. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost-plus contract pricing. The most recent modification was on March 31, 2026. If all options are exercised, the contract could reach $4.22 million.
Contract details
- PIID
- 75N93023C00015
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- New York, NY
- First action
- August 20, 2024
- Latest action
- March 31, 2026
Description
DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE
Modification timeline
-
March 31, 2026Mod P00010 · Other Administrative Action$4.22M
-
September 11, 2025Mod P00009 · Other Administrative Action$4.22M
-
June 27, 2025Mod P00008 · Exercise An Option$4.22M
-
August 20, 2024Mod P00004 · Other Administrative Action$2.96M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 30, 2026 | $493.5K |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93023C00015?
Contract 75N93023C00015 is a federal contract awarded to Ceramedix Holding, Llc by Department Of Health And Human Services on August 20, 2024 for $965,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75N93023C00015?
Ceramedix Holding, Llc won contract 75N93023C00015 from Department Of Health And Human Services.
How much is contract 75N93023C00015 worth?
Contract 75N93023C00015 has obligated $965,000 to date, with a total potential value of $4.22 million if all options are exercised.